Consolidated Statements of Operations and Comprehensive Loss (Unaudited) - USD ($) $ in Thousands	3 Months Ended
	Mar. 31, 2025	Mar. 31, 2024
Income Statement [Abstract]
Revenues	$ 0	$ 0
Operating expenses:
Research and development	41,391	24,103
General and administrative	14,078	9,970
Total operating expenses	55,469	34,073
Loss from operations	(55,469)	(34,073)
Other income (expense):
Amortization of financing costs	(24)	(28)
Interest income, net	9,864	6,745
Total other income, net	9,840	6,717
Net loss	(45,629)	(27,356)
Other comprehensive loss, net of tax:
Unrealized gain (loss) on securities	563	(1,125)
Foreign currency translation loss	9	(85)
Comprehensive loss	$ (45,057)	$ (28,566)
Basic net loss per common share	$ (0.41)	$ (0.26)
Diluted net loss per common share	$ (0.41)	$ (0.26)
Weighted-average shares used to compute basic net loss per share	112,069,078	103,457,305
Weighted-average shares used to compute diluted net loss per share	112,069,078	103,457,305